Publication:
Autophagy in Hematological Malignancies.

Loading...
Thumbnail Image

Date

2022-10-13

Authors

Garcia Ruiz, Olga
Sanchez-Maldonado, Jose Manuel
Lopez-Nevot, Miguel Angel
Garcia, Paloma
Macauda, Angelica
Hernandez-Mohedo, Francisca
Gonzalez-Sierra, Pedro Antonio
Martinez-Bueno, Manuel
Perez, Eva
Reyes-Zurita, Fernando Jesus

Advisors

Journal Title

Journal ISSN

Volume Title

Publisher

MDPI AG
Metrics
Google Scholar
Export

Research Projects

Organizational Units

Journal Issue

Abstract

Autophagy is a highly conserved metabolic pathway via which unwanted intracellular materials, such as unfolded proteins or damaged organelles, are digested. It is activated in response to conditions of oxidative stress or starvation, and is essential for the maintenance of cellular homeostasis and other vital functions, such as differentiation, cell death, and the cell cycle. Therefore, autophagy plays an important role in the initiation and progression of tumors, including hematological malignancies, where damaged autophagy during hematopoiesis can cause malignant transformation and increase cell proliferation. Over the last decade, the importance of autophagy in response to standard pharmacological treatment of hematological tumors has been observed, revealing completely opposite roles depending on the tumor type and stage. Thus, autophagy can promote tumor survival by attenuating the cellular damage caused by drugs and/or stabilizing oncogenic proteins, but can also have an antitumoral effect due to autophagic cell death. Therefore, autophagy-based strategies must depend on the context to create specific and safe combination therapies that could contribute to improved clinical outcomes. In this review, we describe the process of autophagy and its role on hematopoiesis, and we highlight recent research investigating its role as a potential therapeutic target in hematological malignancies. The findings suggest that genetic variants within autophagy-related genes modulate the risk of developing hemopathies, as well as patient survival.

Description

MeSH Terms

Autophagic Cell Death
Neoplasms
Hematologic Neoplasms
Autophagy
Cell Division
Hematopoiesis
Oxidative Stress
Organelles
Metabolic Networks and Pathways
Homeostasis

DeCS Terms

División celular
Estrés oxidativo
Hematopoyesis
Muerte celular autofágica
Neoplasias hematológicas
Neoplasias hematológicas

CIE Terms

Keywords

autophagy, autophagy-related variants, clinical outcomes, disease progression, hematological malignancies, hematopoiesis, patient survival, therapeutic target

Citation

García Ruiz O, Sánchez-Maldonado JM, López-Nevot MÁ, García P, Macauda A, Hernández-Mohedo F, et al . Autophagy in Hematological Malignancies. Cancers (Basel). 2022 Oct 17;14(20):5072.